Andrew Regan

Andrew Regan is a Senior Lecturer in the School of Chemistry at the University of Manchester, specializing in organic synthesis and drug discovery. He holds a B.A. (1981), M.A. (1985), and Ph.D. (1985) from the University of Cambridge. His career includes postdoctoral research at Columbia University and a lectureship at the University of Kent before joining Manchester in 1991.

Research interests focus on synthesizing biologically active compounds, such as phosphinic acids for anticancer agents, and developing novel synthetic methods. His work contributes to drug discovery, green chemistry, and efficient chemical processes. He currently supervises two PhD students researching phosphinic acid analogues and simplified erythromycin analogues.

Key achievements include the synthesis of epibatidine and advancements in macrolide antibiotic design. His research aligns with sustainable development goals through eco-friendly synthesis methods.